A

Aktis Oncology

35 employees

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2021

Funding rounds raised

Total raised

$84M

from 12 investors over 12 rounds

A

Aktis Oncology raised $84M on August 25, 2022

Investors: Octagon Capital Advisors, NS Investment, Pappas Capital, TCG X, MPM Capital, Merck Group and Vida Ventures, LLC

A

Aktis Oncology raised $72M on March 18, 2021

Investors: TCG X, MPM Capital, Octagon Capital Advisors, Bristol-Myers Squibb, UK and Vida Ventures, LLC

FAQ